tiprankstipranks
Alnylam downgraded to Underperform from Peer Perform at Wolfe Research
PremiumThe FlyAlnylam downgraded to Underperform from Peer Perform at Wolfe Research
1M ago
Alnylam price target raised to $298 from $275 at Raymond James
Premium
The Fly
Alnylam price target raised to $298 from $275 at Raymond James
2M ago
Alnylam price target raised to $310 from $305 at Scotiabank
Premium
The Fly
Alnylam price target raised to $310 from $305 at Scotiabank
2M ago
Alnylam sees FY24  combined net product revenues $1.58B – $1.65B
PremiumThe FlyAlnylam sees FY24 combined net product revenues $1.58B – $1.65B
2M ago
Alnylam reports Q3 EPS (50c), consensus (93c)
Premium
The Fly
Alnylam reports Q3 EPS (50c), consensus (93c)
2M ago
ALNY Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ALNY Earnings this Week: How Will it Perform?
2M ago
Alnylam price target raised to $314 from $307 at BofA
PremiumThe FlyAlnylam price target raised to $314 from $307 at BofA
2M ago
Alnylam submits vutrisiran sNDA to FDA
Premium
The Fly
Alnylam submits vutrisiran sNDA to FDA
2M ago
AstraZeneca, CSPC deal shows Lp(a) space remains hot, says BMO Capital
Premium
The Fly
AstraZeneca, CSPC deal shows Lp(a) space remains hot, says BMO Capital
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100